Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Dimethyl Fumarate Te Arai
Active Ingredient: Dimethyl fumarate 120mg
Dosage Form: Modified release capsule
New Zealand Sponsor: Te Arai BioFarma Limited
Manufacturer: Sanovel Ilac Sanayi Ve Ticaret A.S., Istanbul, Turkey
   
Product: Dimethyl Fumarate Te Arai
Active Ingredient: Dimethyl fumarate 240mg
Dosage Form: Modified release capsule
New Zealand Sponsor: Te Arai BioFarma Limited
Manufacturer: Sanovel Ilac Sanayi Ve Ticaret A.S., Istanbul, Turkey
   
Product: Epidyolex
Active Ingredient: Cannabidiol 100mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Chiesi New Zealand Limited t/a Emerge Health
Manufacturer: GW Pharma Limited, Sittingbourne, United Kingdom
   
Product: Pfizer Bendamustine Concentrated Injection
Active Ingredient: Bendamustine hydrochloride monohydrate 26.1mg

equivalent to 25mg bendamustine hydrochloride

Dosage Form: Concentrate for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Zydus Hospira Oncology Limited (ZHOPL), Ahmedabad, India
   
Product: Pfizer Bendamustine Concentrated Injection
Active Ingredient: Bendamustine hydrochloride monohydrate 104.6mg

equivalent to 100mg bendamustine hydrochloride

Dosage Form: Concentrate for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Zydus Hospira Oncology Limited (ZHOPL), Ahmedabad, India
   
Product: Qinlock
Active Ingredient: Ripretinib 50mg
Dosage Form: Tablet
New Zealand Sponsor: Specialised Therapeutics Limited
Manufacturer: Bend Research Inc, Oregon, United States of America


Dated this 13th day of January 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).